Morgan Stanley 4 D Molecular Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,702,339 shares of FDMT stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,702,339

Previous 1,460,234 16.58%

Holding current value

$10.7 Million

Previous $30.7 Million 39.96%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.81 - $27.22 $2.62 Million - $6.59 Million	242,105 Added 16.58%	1,702,339 $18.4 Million
Q2 2024 Oct 17, 2024	SELL	$20.93 - $30.01 $1.87 Million - $2.69 Million	-89,492 Reduced 5.77%	1,460,234 $30.7 Million
Q2 2024 Aug 14, 2024	SELL	$20.93 - $30.01 $1.87 Million - $2.69 Million	-89,492 Reduced 5.77%	1,460,234 $30.7 Million
Q1 2024 Oct 17, 2024	BUY	$17.03 - $35.87 $1.52 Million - $3.21 Million	89,492 Added 6.13%	1,549,726 $49.4 Million
Q1 2024 Aug 16, 2024	SELL	$17.03 - $35.87 $324,557 - $683,610	-19,058 Reduced 1.21%	1,549,726 $49.4 Million
Q1 2024 May 15, 2024	SELL	$17.03 - $35.87 $324,557 - $683,610	-19,058 Reduced 1.21%	1,549,726 $49.4 Million
Q4 2023 Aug 16, 2024	BUY	$9.76 - $21.25 $1.06 Million - $2.31 Million	108,550 Added 7.43%	1,568,784 $31.8 Million
Q4 2023 Feb 13, 2024	BUY	$9.76 - $21.25 $1 Million - $2.19 Million	102,916 Added 7.02%	1,568,784 $31.8 Million
Q3 2023 Nov 15, 2023	SELL	$12.64 - $19.76 $1.29 Million - $2.01 Million	-101,891 Reduced 6.5%	1,465,868 $18.7 Million
Q2 2023 Aug 14, 2023	SELL	$15.16 - $23.26 $2.64 Million - $4.05 Million	-174,118 Reduced 10.0%	1,567,759 $28.3 Million
Q1 2023 May 15, 2023	BUY	$15.45 - $23.19 $4.38 Million - $6.57 Million	283,305 Added 19.42%	1,741,877 $29.9 Million
Q4 2022 Feb 14, 2023	SELL	$6.85 - $25.46 $3.86 Million - $14.3 Million	-563,001 Reduced 27.85%	1,458,572 $32.4 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.48 $11.9 Million - $19.6 Million	1,708,534 Added 545.79%	2,021,573 $16.3 Million
Q2 2022 Oct 27, 2022	SELL	$5.68 - $15.99 $607,742 - $1.71 Million	-106,997 Reduced 25.47%	313,039 $2.19 Million
Q2 2022 Aug 15, 2022	SELL	$5.68 - $15.99 $607,742 - $1.71 Million	-106,997 Reduced 25.47%	313,039 $2.19 Million
Q1 2022 Oct 27, 2022	BUY	$13.16 - $22.64 $1.41 Million - $2.42 Million	106,997 Added 34.18%	420,036 $6.35 Million
Q1 2022 May 13, 2022	SELL	$13.16 - $22.64 $184,792 - $317,910	-14,042 Reduced 3.23%	420,036 $6.35 Million
Q4 2021 Feb 14, 2022	BUY	$19.56 - $32.94 $1.28 Million - $2.16 Million	65,627 Added 17.81%	434,078 $9.52 Million
Q3 2021 Nov 15, 2021	BUY	$22.73 - $36.04 $8.37 Million - $13.3 Million	368,451 New	368,451 $9.94 Million

Others Institutions Holding FDMT

# of Institutions

144

Shares Held

57.7M

Call Options Held

137K

Put Options Held

111K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $204M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account